Anzeige
Mehr »
Login
Sonntag, 07.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Bam Bam Resources und die Mega-Kupferlagerstätte in Teslas Hinterhof!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AN1Z ISIN: SE0000767188 Ticker-Symbol: 7AL 
Frankfurt
05.03.21
10:37 Uhr
0,645 Euro
+0,004
+0,62 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ALLIGATOR BIOSCIENCE AB Chart 1 Jahr
5-Tage-Chart
ALLIGATOR BIOSCIENCE AB 5-Tage-Chart

Aktuelle News zur ALLIGATOR BIOSCIENCE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.02.Change in number of shares and votes in Alligator Bioscience AB-
26.02.Alligator Bioscience reports Q4 results-
26.02.Alligator Bioscience AB: Year-end Report January-December 2020165Continued focus on clinical development. STOCKHOLM, Feb. 26, 2021 /PRNewswire/ -- "Safety data has been presented from the ongoing Phase I study with ATOR-1017 in patients with...
► Artikel lesen
ALLIGATOR BIOSCIENCE Aktie jetzt für 0€ handeln
24.02.Nasdaq Stockholm AB: Delisting of paid subscription shares in Alligator Bioscience AB (26/21)189The paid subscription shares in Alligator Bioscience AB will be delisted. Last trading day for ATORX BTA will be on February 26, 2021. Instrument: Paid subscription shares --------------------------------------- Short...
► Artikel lesen
23.02.Alligator Bioscience AB: Last day of trading in paid subscription shares (Sw. BTA)183STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- Last day of trading in BTA in Alligator Bioscience AB ("Alligator" or the "Company") will be Friday February 26, 2021 and stop day will be Tuesday...
► Artikel lesen
27.01.Alligator Bioscience's rights issue oversubscribed242STOCKHOLM, Jan. 27, 2021 /PRNewswire/ -- Alligator Bioscience AB (publ) ("Alligator" or the "Company") has completed the share issue with pre-emption rights for the Company's shareholders...
► Artikel lesen
21.01.ALLIGATOR BIOSCIENCE: Larger shareholder and board member transfer subscription rights free of charge to qualified investors-
15.01.Alligator Bioscience appoints Chief Scientific Officer1
11.01.The subscription period in Alligator Bioscience's rights issue commences today246NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, CANADA, NEW ZEALAND, SOUTH AFRICA, JAPAN, AUSTRALIA, SOUTH KOREA, HONG KONG...
► Artikel lesen
07.01.Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Alligator Bioscience AB (3/21)197With effect from 1/11/2021, the subscription rights in Alligator Bioscience AB will be traded on the list for Equity rights. Trading will continue up until and including 1/21/2021. Instrument: ...
► Artikel lesen
31.12.20XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2020520CAPITAL ADJUSTMENT INFORMATION - 04.01.2021:Das Instrument HGM GB0032360173 HIGHLAND GOLD MNG LS-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2020 und ex Kapitalmassnahme am 04.01.2021 The...
► Artikel lesen
30.12.20Alligator Bioscience publishes prospectus in connection with forthcoming rights issue263STOCKHOLM, Dec. 30, 2020 /PRNewswire/ -- The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has, in connection with the rights issue of shares which was...
► Artikel lesen
29.12.20Alligator Bioscience appoints new Chief Medical Officer3
29.12.20Alligator Bioscience recruits new Chief Medical Officer284LUND, Sweden, Dec. 29, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Dr Christina Reimer as Chief Medical Officer. She...
► Artikel lesen
28.12.20Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1286LUND, Sweden, Dec. 28, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has submitted a CTA (Clinical Trial Authorization) application to the relevant...
► Artikel lesen
15.12.20ALLIGATOR BIOSCIENCE: Alligator carries out a fully guaranteed rights issue of approximately SEK 86m1
10.12.20Alligator Bioscience launches ALLIGATOR-FAB - a novel human antibody library214LUND, Sweden, Dec. 10, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of a novel proprietary human synthetic antibody library in Fab (Fragment...
► Artikel lesen
04.12.20Alligator Bio on go with mitazalimab clinical trials in the U.S.2
04.12.20Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimab279LUND, Sweden, Dec. 4, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an approved IND (Investigational new Drug) for the CD40 targeting antibody mitazalimab....
► Artikel lesen
20.11.20Nomination Committee appointed in respect of AGM 2021 in Alligator Bioscience AB1
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1